Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.
Cerecin produces Ketasyn which is a molecule for Alzheimer's, Parkinson's, and other age associated memory impairments. The company was founded by Mark Heiman, Samuel Henderson, and Steve Orndorff in 2001, in Denver, Colorado, United States.